Therefore, it is possible that overexpression of HOXA9 or HOXA10 alone may be sufficient to cooperate with BCR/ABL to induce transformation of GMPs, leading to CML progression into myeloid blast crisis; however, this hypothesis has not been tested. The gene discussed is HOXA9; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.